Multinational team focused on curing cancer with cell therapy & immuno-engineering. Product safety, efficacy, reproducibility, and affordability are key.
Cleveland, OH
Joined January 2022
- Tweets140
- Following139
- Followers218
- Likes393
MelenhorstLab retweeted
👏 Congrats to Prof. @carlhjune on receiving the @AbarcaPrize! His pioneering work in CAR-T therapy has transformed cancer treatment. During my time in his lab, I had the chance to experience his inspiring vision and trust, for which I am deeply grateful.
abarcaprize.com/award-winner…
MelenhorstLab retweeted
Excited to share our latest work on an image analysis paradigm that combines cell state and morphology analyses of patient biopsies at single cell resolution to uncover clinically relevant head-and-neck #cancer phenotypes! @CellCellPress cell.com/cell/fulltext/S0092… tweetorial👇
MelenhorstLab retweeted
Super cool to see our work highlighted by @ACIR_org If you haven’t had a chance to check it out yet this is a great summary!
New insights into nivolumab-induced immunoediting bit.ly/403lMIZ @TylerAlban1 @xrtGenomics @GeneCollector
MelenhorstLab retweeted
Super excited to share the final publication of Spectra, fruit of the wonderful collaboration between
@russell_kunes and @science_wallet, a gene program factorization program that I hope will help many interpret and bring insight from their single-cell data -->
Had my favorite book in my checked in luggage - which apparently left out in the rain. Now I am thinking again: buy the book or read this tortured copy? Thoughts?
North Korea tensions: Why is Kim Jong-un upping the pressure? Not so super, man! bbc.co.uk/news/world-asia-63…
Nedd Brockmann: The man who ran across Australia in 47 days…
Superman.. bbc.co.uk/news/world-austral…
MelenhorstLab retweeted
We are looking for doctors who are interested in Hematology and Oncology Hospitalist positions @ClevelandClinic practicematch.com/CareerCent… – at Solon, OH
At today’s Chagrin Falls Documentary Film festival where I was invited for the Q&A following Ross Kauffman’s Of Medicine and Miracles movie showing. Made new friends, reconnected with Tom Whitehead. Saw Carl in this movie as I know him: Brilliant, inspiring, miles ahead of every1
MelenhorstLab retweeted
Bioicons.com
Here is an alternative to BioRender that is TRULY FREE and actively maintained. Over 1500 vectorized images sorted by license type (all creative commons or MIT). Fully editable icons and soon they will launch an Inkscape library.
I wouldn’t say “starting” but “advancing our understanding..”. Great progress with high translational potential! statnews.com/2022/10/04/why-…
MelenhorstLab retweeted
Excited to share TEMPOmap, our new spatiotemporal transcriptomics method that integrates metabolic labeling with 3D in situ sequencing to simultaneously profile the age and location of individual RNA molecules led by @JingyiRen Haowen Zhou and @huzengHZ biorxiv.org/content/10.1101/…
MelenhorstLab retweeted
Cleveland Clinic is selected as the leading healthcare system in a new initiative to accelerate collaboration and innovation in quantum computing.
Developed by @ConnectedDMV, this hub leverages our partnership with @IBMResearch to advance medicine. cle.clinic/3UKK6dz
MelenhorstLab retweeted
Applications open for a pediatric oncology physician scientist. Pediatric neuro-oncology focused clinical practice and laboratory program. Contact below to apply. Great opportunity to join a top cancer program.
practicematch.com/physicians…
MelenhorstLab retweeted
CAR-T Day in Lille France has been a wonderful meeting. Highly recommended! @MelenhorstLab @PaulosLab @KlebanoffLab @EvanWeberPhD #SumanMitra #JimKochenderfer #RobertaDiBlasi
Interesting work from Scholler, Galon and colleagues on the baseline and post-CAR T cell treatment tumor microenvironment analysis. Plenty of material for mechanistic studies. Congrats to the team! nature.com/articles/s41591-0…
MelenhorstLab retweeted
Honored and humbled to be inducted to NAI. Believe in technology innovation for science, humanity, inclusion and patients! @AcadofInventors #NAI2022
MelenhorstLab retweeted
Collaborators at @UPennIBI and @YaleBME unveiled molecular mechanisms ⚙️ that may inform strategies to boost specific T cell function to maintain long-term remission in acute lymphoblastic #leukemia patients.
@MelenhorstLab @camara_pg @RongFan8
📎 bit.ly/3xxOymd
MelenhorstLab retweeted
Impressive phase 1 trial results testing a Claudin18.2-specific CAR in patients with R/R #GImalignancies. Favorable toxicity profile and correlation between T cell persistence and antitumor efficacy. @NatureMedicine
Promising result from phase 1 Claudin18.2 CAR-T clinical trial against gastric cancer(solid tumor), great to see CD3/CD28 dynabeads used for CAR-T manufacturing in this trial:
nature.com/articles/s41591-0…
#celltherapy #carttherapy
